Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4AF0

Crystal structure of cryptococcal inosine monophosphate dehydrogenase

Summary for 4AF0
Entry DOI10.2210/pdb4af0/pdb
DescriptorINOSINE-5'-MONOPHOSPHATE DEHYDROGENASE, MYCOPHENOLIC ACID, INOSINIC ACID, ... (6 entities in total)
Functional Keywordsoxidoreductase, gtp biosynthesis, drug resistance
Biological sourceCRYPTOCOCCUS NEOFORMANS
More
Cellular locationCytoplasm (By similarity): E3P6S0 E3P6S0
Total number of polymer chains2
Total formula weight120269.92
Authors
Valkov, E.,Stamp, A.,Morrow, C.A.,Kobe, B.,Fraser, J.A. (deposition date: 2012-01-15, release date: 2012-10-24, Last modification date: 2023-12-20)
Primary citationMorrow, C.A.,Valkov, E.,Stamp, A.,Chow, E.W.L.,Lee, I.R.,Wronski, A.,Williams, S.J.,Hill, J.M.,Djordjevic, J.T.,Kappler, U.,Kobe, B.,Fraser, J.A.
De Novo GTP Biosynthesis is Critical for Virulence of the Fungal Pathogen Cryptococcus Neoformans
Plos Pathog., 8:2957-, 2012
Cited by
PubMed Abstract: We have investigated the potential of the GTP synthesis pathways as chemotherapeutic targets in the human pathogen Cryptococcus neoformans, a common cause of fatal fungal meningoencephalitis. We find that de novo GTP biosynthesis, but not the alternate salvage pathway, is critical to cryptococcal dissemination and survival in vivo. Loss of inosine monophosphate dehydrogenase (IMPDH) in the de novo pathway results in slow growth and virulence factor defects, while loss of the cognate phosphoribosyltransferase in the salvage pathway yielded no phenotypes. Further, the Cryptococcus species complex displays variable sensitivity to the IMPDH inhibitor mycophenolic acid, and we uncover a rare drug-resistant subtype of C. gattii that suggests an adaptive response to microbial IMPDH inhibitors in its environmental niche. We report the structural and functional characterization of IMPDH from Cryptococcus, revealing insights into the basis for drug resistance and suggesting strategies for the development of fungal-specific inhibitors. The crystal structure reveals the position of the IMPDH moveable flap and catalytic arginine in the open conformation for the first time, plus unique, exploitable differences in the highly conserved active site. Treatment with mycophenolic acid led to significantly increased survival times in a nematode model, validating de novo GTP biosynthesis as an antifungal target in Cryptococcus.
PubMed: 23071437
DOI: 10.1371/JOURNAL.PPAT.1002957
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

249524

PDB entries from 2026-02-18

PDB statisticsPDBj update infoContact PDBjnumon